[ad_1]
For years, the number “10,000 steps” has carried almost mythical status. You see it on your fitness tracker, hear it in health advice, and maybe even use it as a personal benchmark. But the idea wasn’t born from hard science. It actually originated from a Japanese marketing campaign in the 1960s to sell pedometers.
[ad_2]
[ad_1]
How and why to train at a lower heart rate to lose weight, improve aerobic fitness, and prevent injury.
[ad_2]
[ad_1]
Some movement is always better than none. However, once you get in the habit of exercising regularly, you’ll probably begin to wonder how you can optimize this process to match your goals. If you’re aiming for peak cardiac health, a study finds the “weekend warrior” approach may be for you.
[ad_2]
[ad_1]
It’s no secret that quality sleep is an integral part of our overall well-being, but the more we come to know about sleep, the more we learn about how it truly affects the body. And according to a study published in European Heart Journal–Digital Health, the heart is no exception. Here’s what researchers discovered when studying how bedtimes affect heart health.
[ad_2]
[ad_1]
Beauty & Health Editor
Hannah Frye is the Beauty & Health Editor at mindbodygreen. She has a B.S. in journalism and a minor in women’s, gender, and queer studies from California Polytechnic State University, San Luis Obispo. Hannah has written across lifestyle sections including beauty, women’s health, mental health, sustainability, social media trends, and more. She previously worked for Almost 30, a top-rated health and wellness podcast. In her current role, Hannah reports on the latest beauty trends and innovations, women’s health research, brain health news, and plenty more.
[ad_2]
[ad_1]
Doctors may soon have a new way to treat high blood pressure, even among people for whom medicines haven’t worked well in the past.Baxdrostat, an experimental medicine made by AstraZeneca, showed promise in treating people with uncontrolled or resistant high blood pressure in a recent trial. If the medicine gets approved by regulatory authorities, it will be one of the first new approaches to treating high blood pressure in decades, researchers say.Scientists presented the trial results Saturday at the European Society of Cardiology Congress 2025 in Madrid and simultaneously published them in the New England Journal of Medicine.For the study, researchers enrolled 800 adults who still had high blood pressure after taking two or more medications for at least four weeks. To qualify for the study, patients’ systolic blood pressure had to be between 140 and 170.Blood pressure is measured in millimeters of mercury, which is abbreviated as mm Hg. The measurement has an upper number, or systolic reading, and a lower number, a diastolic reading. Systolic pressure measures the force of blood as it pumps out of the heart into the arteries; diastolic is the pressure created as the heart rests between beats.Normal blood pressure is less than 120/80 mm Hg, and elevated blood pressure is considered to be from 120 to 129/80 mm Hg. At 130/80 mmHg or higher, according to new U.S. guidelines, a person’s medical provider will want them to take a blood pressure medication if lifestyle changes — including eating healthier, reducing salt in the diet and exercising more — don’t work first.The researchers on the new trial placed the participants into three groups. One received 1 milligram of baxdrostat, another got 2 mg, and another got a placebo, which does nothing. Participants took their dose in addition to medicines they were already taking.At 12 weeks, about 4 in 10 patients taking baxdrostat reached healthy blood pressure levels, compared with less than 2 in 10 who got a placebo.Specifically, participants who got 1 or 2 mg of baxdrostat daily saw their systolic blood pressure – the upper number in the reading – fall around 9 to 10 mm Hg more than those taking a placebo. This reduction, studies show, is large enough to cut cardiovascular risk.When blood pressure is high, the force of the blood pushes against the walls of their blood vessels, making the heart less efficient: Both the vessels and the heart must work harder, and it’s more difficult to get blood to essential organs and cells. Without treatment, high blood pressure will eventually damage the arteries, raising the risk of conditions like a heart attack, stroke, coronary disease, vascular dementia and cognitive problems.Heart disease is the No. 1 killer in the world. Lowering blood pressure is the most modifiable way to avoid such a death.Nearly half of all adults in the U.S. have higher than normal blood pressure, and 1 in 10 people have what doctors call resistant hypertension: Despite being on three or more medications, they are not meeting the goal for blood pressure control.When a patient has high blood pressure, doctors may need to try a variety of medications to see what works best.Adding baxdrostat to the list of options could be a big help for patients, according to Dr. Stacey E. Rosen, volunteer president of the American Heart Association, who was not involved with the new research.“What’s interesting about this medication is that they can really be a wonderful partner, so to speak, with some of the more classically recommended anti-hypertensive medications,” said Rosen, who is also a senior vice president of women’s health and executive director of the Katz Institute for Women’s Health of Northwell Health in New York City.Medication options now on the market control blood pressure in a variety of ways. Some, such as vasodilators, relax and widen arteries and veins to allow blood to get through easier and increase flow. Diuretics primarily work by removing excess fluid and salt from the body by increasing urine production. Centrally acting alpha agonists help prevent the nervous system from responding to stress. ACE inhibitors keep the body from producing angiotensin II, a hormone that makes blood vessels constrict. ARBs, or angiotensin II receptor blockers, help reduce the production of aldosterone, a hormone that promotes salt and water retention. Calcium channel blockers can keep calcium away from the cells of the heart and arteries so they don’t have to work as hard.Each can have different side effects, including dizziness, rapid or slower heart rate, exhaustion, upset stomach and swelling in the legs.Baxdrostat’s side effects, the study showed, were mild overall. The most common problem was abnormalities in potassium and sodium levels, but this was rare.Baxdrostat takes a new approach to managing high blood pressure. It focuses on blocking aldosterone, a hormone created by the adrenal glands that helps kidneys regulate salt and maintain the body’s water balance. Some people produce too much aldosterone, leading their body to retain too much water and salt, pushing up blood pressure.“We’ve also known for a while now that most of us eat too much salt and in doing that, it raises blood pressure. But we’re also increasingly recognizing that aldosterone may have a direct impact on causing damage to the blood vessels, to the heart, to the kidneys,” said Dr. Jenifer Brown, one of the lead investigators and co-author of the published study.Brown said she often sees cardiology patients at Brigham and Women’s who may have had a heart event, so she needs to be aggressive in getting their blood pressure under control to prevent another. Some patients may have trouble tolerating other blood pressure medications. For others, the standard medicines just don’t work well. Baxdrostat could be a good complement, she said.“We really have had the same tools as clinicians for many years,” Brown said. “I would be excited to have an option like this.”In an editorial accompanying the publication, Dr. Tomasz Guzik, a cardiovascular scientist at the University of Edinburgh, and Dr. Maciej Tomaszewski, a cardiovascular expert at the University of Manchester, write that next steps should be to figure out which patients would best respond to this new medicine and provide longer-term data. If the medication works long-term, they wrote, it could become a “central piller of therapy for difficult-to-control hypertension.”AstraZeneca said it plans to submit its data to regulatory agencies before the end of 2025.
Doctors may soon have a new way to treat high blood pressure, even among people for whom medicines haven’t worked well in the past.
Baxdrostat, an experimental medicine made by AstraZeneca, showed promise in treating people with uncontrolled or resistant high blood pressure in a recent trial. If the medicine gets approved by regulatory authorities, it will be one of the first new approaches to treating high blood pressure in decades, researchers say.
Scientists presented the trial results Saturday at the European Society of Cardiology Congress 2025 in Madrid and simultaneously published them in the New England Journal of Medicine.
For the study, researchers enrolled 800 adults who still had high blood pressure after taking two or more medications for at least four weeks. To qualify for the study, patients’ systolic blood pressure had to be between 140 and 170.
Blood pressure is measured in millimeters of mercury, which is abbreviated as mm Hg. The measurement has an upper number, or systolic reading, and a lower number, a diastolic reading. Systolic pressure measures the force of blood as it pumps out of the heart into the arteries; diastolic is the pressure created as the heart rests between beats.
Normal blood pressure is less than 120/80 mm Hg, and elevated blood pressure is considered to be from 120 to 129/80 mm Hg. At 130/80 mmHg or higher, according to new U.S. guidelines, a person’s medical provider will want them to take a blood pressure medication if lifestyle changes — including eating healthier, reducing salt in the diet and exercising more — don’t work first.
The researchers on the new trial placed the participants into three groups. One received 1 milligram of baxdrostat, another got 2 mg, and another got a placebo, which does nothing. Participants took their dose in addition to medicines they were already taking.
At 12 weeks, about 4 in 10 patients taking baxdrostat reached healthy blood pressure levels, compared with less than 2 in 10 who got a placebo.
Specifically, participants who got 1 or 2 mg of baxdrostat daily saw their systolic blood pressure – the upper number in the reading – fall around 9 to 10 mm Hg more than those taking a placebo. This reduction, studies show, is large enough to cut cardiovascular risk.
When blood pressure is high, the force of the blood pushes against the walls of their blood vessels, making the heart less efficient: Both the vessels and the heart must work harder, and it’s more difficult to get blood to essential organs and cells. Without treatment, high blood pressure will eventually damage the arteries, raising the risk of conditions like a heart attack, stroke, coronary disease, vascular dementia and cognitive problems.
Heart disease is the No. 1 killer in the world. Lowering blood pressure is the most modifiable way to avoid such a death.
Nearly half of all adults in the U.S. have higher than normal blood pressure, and 1 in 10 people have what doctors call resistant hypertension: Despite being on three or more medications, they are not meeting the goal for blood pressure control.
When a patient has high blood pressure, doctors may need to try a variety of medications to see what works best.
Adding baxdrostat to the list of options could be a big help for patients, according to Dr. Stacey E. Rosen, volunteer president of the American Heart Association, who was not involved with the new research.
“What’s interesting about this medication is that they can really be a wonderful partner, so to speak, with some of the more classically recommended anti-hypertensive medications,” said Rosen, who is also a senior vice president of women’s health and executive director of the Katz Institute for Women’s Health of Northwell Health in New York City.
Medication options now on the market control blood pressure in a variety of ways. Some, such as vasodilators, relax and widen arteries and veins to allow blood to get through easier and increase flow. Diuretics primarily work by removing excess fluid and salt from the body by increasing urine production. Centrally acting alpha agonists help prevent the nervous system from responding to stress. ACE inhibitors keep the body from producing angiotensin II, a hormone that makes blood vessels constrict. ARBs, or angiotensin II receptor blockers, help reduce the production of aldosterone, a hormone that promotes salt and water retention. Calcium channel blockers can keep calcium away from the cells of the heart and arteries so they don’t have to work as hard.
Each can have different side effects, including dizziness, rapid or slower heart rate, exhaustion, upset stomach and swelling in the legs.
Baxdrostat’s side effects, the study showed, were mild overall. The most common problem was abnormalities in potassium and sodium levels, but this was rare.
Baxdrostat takes a new approach to managing high blood pressure. It focuses on blocking aldosterone, a hormone created by the adrenal glands that helps kidneys regulate salt and maintain the body’s water balance. Some people produce too much aldosterone, leading their body to retain too much water and salt, pushing up blood pressure.
“We’ve also known for a while now that most of us eat too much salt and in doing that, it raises blood pressure. But we’re also increasingly recognizing that aldosterone may have a direct impact on causing damage to the blood vessels, to the heart, to the kidneys,” said Dr. Jenifer Brown, one of the lead investigators and co-author of the published study.
Brown said she often sees cardiology patients at Brigham and Women’s who may have had a heart event, so she needs to be aggressive in getting their blood pressure under control to prevent another. Some patients may have trouble tolerating other blood pressure medications. For others, the standard medicines just don’t work well. Baxdrostat could be a good complement, she said.
“We really have had the same tools as clinicians for many years,” Brown said. “I would be excited to have an option like this.”
In an editorial accompanying the publication, Dr. Tomasz Guzik, a cardiovascular scientist at the University of Edinburgh, and Dr. Maciej Tomaszewski, a cardiovascular expert at the University of Manchester, write that next steps should be to figure out which patients would best respond to this new medicine and provide longer-term data. If the medication works long-term, they wrote, it could become a “central piller of therapy for difficult-to-control hypertension.”
AstraZeneca said it plans to submit its data to regulatory agencies before the end of 2025.
[ad_2]
[ad_1]
People who want to get an updated COVID-19 vaccine at CVS or Walgreens pharmacies in Colorado this fall will need to present a prescription.
State law allows pharmacists to administer vaccines recommended by the Advisory Committee on Immunization Practices, a group that counsels the director of the Centers for Disease Control and Prevention about who will benefit from which shots.
In previous years, the committee recommended updated COVID-19 vaccines within days of the U.S. Food and Drug Administration approving them. This year, the committee doesn’t have any meetings scheduled until late September, and may not recommend the shot when it does meet, since Secretary of Health and Human Services Robert F. Kennedy Jr. appointed multiple members with anti-vaccine views after removing all prior appointees in June.
The lack of a recommendation also means that insurance companies aren’t legally required to pay for the COVID-19 vaccine without out-of-pocket costs. Most private insurers will cover the updated shots this year, though that could change in 2026, according to Reuters.
Initially, CVS said it couldn’t give the COVID-19 vaccine to anyone in Colorado or 15 other states, because of their ACIP-approval requirement. As of Friday morning, its pharmacies can offer the shots to eligible people who have a prescription, spokeswoman Amy Thibault said.
As of about 10 a.m. Friday, CVS’s website wouldn’t allow visitors to schedule COVID-19 shots in Colorado.
Walgreens didn’t respond to questions about its COVID-19 vaccine policy, but its website said patients need a prescription in Colorado. A New York Times reporter found the same in 15 other states.
The FDA this week recommended the updated shots only for people who are over 65 or have a health condition that puts them at risk for severe disease.
The listed conditions include:
Healthy people technically still can get the vaccine, but would have to ask a health care provider to prescribe it off-label. An off-label prescription refers to one given for a condition the drug isn’t approved to treat, such as a blood-pressure drug prescribed to prevent migraines.
Not everyone has a regular health care provider or the inclination to take time out of their day for an office visit, though. Insurers also vary in their willingness to cover off-label prescriptions.
Sign up for our weekly newsletter to get health news sent straight to your inbox.
[ad_2]
Meg Wingerter
Source link
[ad_1]
On sweltering Tuesday, June 24, folks enjoying a day on the beach or on the water and city lifeguards jumped into action in two separate water rescues about seven hours apart to save the lives of three children and a 77-year-old man.
The first rescue by bystanders and lifeguards involved an older man who suffered a medical emergency while swimming at Good Harbor Beach around 12:30 p.m.
kAm%96 D64@?5 92CC@H:?8 C6D4F6 :?G@=G65 2 AC:G2E6 3@2E6C A=F4<:?8 E9C66 49:=5C6? 7C@> E96 p??:DBF2> #:G6C 2E f A]>]k^Am
kAmsFC:?8 2 DA64:2= 46C6>@?J (65?6D52J ?:89E 😕 r:EJ w2==’D zJC@FK pF5:E@C:F> 2EE6?565 3J 23@FE fd A6@A=6[ E96D6 C6D4F6CD H6C6 ?@E @?=J 9@?@C65 H:E9 4:E2E:@?D @C >652=D 2?5 H@C5D @7 AC2:D6 7C@> @77:4:2=D[ E96 >2J@C[ 4:EJ 4@F?4:=@CD 2?5 DE2E6 $6?2E6 |:?@C:EJ {6256C qCF46 %2CC[ E96J H6C6 9@?@C65 3J >66E:?8 H:E9 E9@D6 H9@ E96J D2G65]k^Am
kAm(96? E96 `_>:?FE6 46C6>@?J 6?565[ E9@D6 82E96C65 =:?86C65 😕 E96 2F5:E@C:F> 7@C A:4EFC6D[ 9F8D[ 92?5D92<6D[ D>:=6D[ 2AA=2FD6[ E62CD 2?5 H6==H:D96D]k^Am
kAm“p?5 H92E DE2CE65 @FE E@ 36 2 H@?56C7F= 52J 2E E96 36249 EFC?65 D@FC AC6EEJ BF:4<]” w6 D2:5 96 H2D “E6CC:3=J =F4
kAm%9@D6 9@?@C65 H:E9 4:E2E:@?D 7@C E96 v@@5 w2C3@C q6249 C6D4F6 H6C6ik^Am
kAm— #6E:C65 ?FCD6 s63 {:24@D]k^Am
kAm— ~?5FEJ =:768F2C5D |:DDJ {@9?6D 2?5 y@9? s2=@?6]k^Am
kAm— ~775FEJ ?FCD6 r2C@=:?6 ~’qC:6?[ H9@ H2D F?23=6 E@ 2EE6?5]k^Am
kAm%9@D6 9@?@C65 H:E9 E96 4:EJ’D |2C:?6CD |652= 7@C E96 p??:DBF2> #:G6C C6D4F6 H6C6ik^Am
kAm— r9C:DE:2? s28=6J[ E96 A:=@E @7 2 3@2E H9@ A=F4<65 E9C66 49:=5C6? 7C@> E96 C:G6C[ E96 D64@?5 E:>6 96 92D 366? 2H2C565 E9:D >652=]k^Am
kAm— z6CC: p?? !6CCJ[ 2? @775FEJ ?FCD6 H9@ AC@G:565 r!# E@ 2 dJ62C@=5 8:C= 2D s28=6J >@E@C65 E96> E@ D9@C6 E@ 7:CDE C6DA@?56CD @? E96 5@4
kAm— y@9? 2?5 r9C:DE:?6 |2?6J[ H9@ 3C@F89E EH@ @7 E96 49:=5C6? E@ E96 5@4< 😕 E96:C 3@2E]k^Am
kAm~? 92?5 E@ >66E E96:C C6D4F6CD H6C6 EH@ @7 E96 E9C66 49:=5C6? D2G65 E92E 52J[ tE92? }8FJ6?[ g[ 2?5 9:D D:DE6C z6:=J }8FJ6?[ d[ 2?5 E96:C A2C6?ED {@?8 }8FJ6? 2?5 w2?8 wFJ?9 @7 {@H6==] p E66?286 8:C=[ 2 C6=2E:G6 H9@ H2D 2=D@ C6D4F65 E92E 52J[ 4@F=5 ?@E 2EE6?5]k^Am
kAm“tG6CJ@?6’D ~z[” {@?8 }8FJ6? D2:5] w:D 52F89E6C 925 366? 😕 4C:E:42= 4@?5:E:@? 😕 E96 xr& 3FE ?@H D96’D 324< E@ ?@C>2=]k^Am
kAm“x ;FDE H2?E E@ D2J ‘E92?< J@F 7@C 6G6CJE9:?8[’ J@F @H[” {@?8 }8FJ6? D2:5] “(:E9@FE E96> WE96 C6D4F6CDX[ :E H@F=5 36 2 5:776C6?E DE@CJ[ D@ x >62? E96J 2C6 >J 96C@6D[ x >62?[ >J <:5D’ 96C@6D]”k^Am
kAmr:EJ @77:4:2=D 925 AC6G:@FD=J D2:5 2 AC6=:>:?2CJ :?G6DE:82E:@? 2AA62C65 E@ D9@H E96 E9C66 49:=5C6? H6C6 DH:>>:?8 2E (:?826CD966< q6249 H96? E96J H2?56C65 @77 2 D2?532C 2?5 :?E@ E96 4FCC6?E E92E BF:4<=J AF==65 E96> 2H2J 7C@> E96 D9@C6]k^Am
kAm“$@ v=@F46DE6C[ 46CE2:?=J 92D A6@A=6 H9@ 2C6 H:==:?8 E@ DE6A FA 2?5 ;F>A 😕 H96? 96=A 😀 ?66565[” 96 D2:5]k^Am
kAm’6C82 2=D@ E92?<65 E96 677@CED @7 9:D 76==@H |2C:?6CD |652= r@>>:EE66 G@=F?E66CD %@> t==:D[ |6=:DD2 r@I[ !9:= rFDF>2?@ 2?5 s2G:5 !62C46[ H9@ C646?E=J >6E @? D9@CE ?@E:46 E@ 2AAC@G6 E96 2H2C5:?8 E@ E96 >652=D]k^Am
kAmr:EJ r@F?4:= !C6D:56?E %@?J vC@DD D2:5 E96 C64:A:6?ED 6A:E@>:K6 H92E E96 |2C:?6CD |652=[ 56D:8?65 3J E96 72>@FD p>6C:42? D4F=AE@C (2=<6C w2?4@4<[ 😀 2== 23@FE]k^Am
kAm“xE’D 23@FE 6I46AE:@?2= 96C@:D>[ 3C2G6CJ[ D6=7=6DD?6DD[ D62>2?D9:A 2?5 6G6CJE9:?8 v=@F46DE6C 😀 7@F?565 FA@?[” vC@DD D2:5]k^Am
kAm“q642FD6 H6 =:G6 @? r2A6 p??[ H6 2C6 3=6DD65 E@ 36 ?62C E96 @462?[” %2CC D2:5] “xE’D A2CE @7 @FC =:G6D] xE’D A2CE @7 @FC :56?E:EJ 2?5 :E’D A2CE @7 H9@ H6 2C6] qFE H6 F?56CDE2?5 E92E 36:?8 ?62C E96 @462? 2?5 36:?8 2 A@CE >62?D E92E :E 4@>6D H:E9 C6DA@?D:3:=:E:6D 2D H6==]k^Am
kAm“~?6 @7 E9@D6 C6DA@?D:3:=:E:6D 😀 E@ 36 8@@5 DE6H2C5D @7 E96 ?2EFC2= 6?G:C@?>6?E 2?5 E96 >2C:?6 C6D@FC46D H6 2C6 3=6DD65 H:E9] qFE 2?@E96C :>A@CE2?E C6DA@?D:3:=:EJ 😀 E@ C64@8?:K6 E92E 😕 E96 >2C:?6 6?G:C@?>6?E … 6G6CJ @?6 @7 FD H9@ G6?EFC6D FA@? E96 H2E6CD @C H9@ 😀 😕 E96 H2E6CD 😀 GF=?6C23=6 2?5 6G6CJ @?6 @7 FD 92D 2? @3=:82E:@? E@ 255C6DD 😕 2 E:>6 @7 ?665 D@>6@?6 H9@ 😀 😕 E92E GF=?6C23=6 A@D:E:@?]”k^Am
kAm“xE’D 2 8C62E 9@?@C[” s28=6J D2:5 @7 36:?8 2H2C565 E96 |2C:?6CD |652=] ‘xE’D 2 8C62E @FE4@>6]”k^Am
kAmy@9? |2?6J D2:5 96 H2D 369:?5 s28=6J’D 3@2E 😕 E96 492??6= 2?5 D2H s28=6J =62G6 E96 492??6= 2?5 5:G6 😕 E96 H2E6C[ 2?5 E9@F89E D@>6E9:?8 H2D 8@:?8 @?]k^Am
kAmw6 AC2:D65 E96 C2A:5 C6DA@?D6 @7 E96 4:EJ[ A@=:46 2?5 7:C67:89E6C 2?5 w2C3@C>2DE6C r9C:D {F4:5@ 27E6C r9C:DE:?6 |2?6J 5:2=65 h“]k^Am
kAm%2CC D2:5 96 2?5 DE2E6 #6A] p??|2C82C6E u6CC2?E6[ sv=@F46DE6C[ H9@ H2D ?@E 😕 2EE6?52?46[ H6C6 9@?@C65 E@ @776C 4:E2E:@?D E@ D2J E92?< J@F “7@C E96 492C24E6C J@F D9@H65 😕 E96 7246 @7 25G6CD:EJ 2?5 E92?< J@F 7@C FA9@=5:?8 E96 7:?6DE EC25:E:@? @7 E9:D 4@>>F?:EJ[ AC@E64E:?8 =:76 2E D62]”k^Am
kAmp7E6C E96 46C6>@?J[ rC@4<6C DE@@5 H:E9 {@9?6D[ `h[ 2?5 D2:5 “D96’D E96 @?6 E92E 24EF2==J 3C@F89E >6 324< E@ =:76]” rC@4<6C D2:5 :E H2D {:24@D H9@ 925 DE2CE65 496DE 4@>AC6DD:@?D 2?5 8@E 2 =@E @7 H2E6C @FE @7 9:>[ “3FE :E H2D |:DDJ E92E 42>6 5@H? 2?5 24EF2==J 5:5 E96 ;@3 @? E96 7:CDE D9@4<” @7 2? 2FE@>2E65 6IE6C?2= 567:3C:==2E@C]k^Am
kAmrC@4<6C D2:5 9:D H:76 925 5C@AA65 9:> @77 2E v@@5 w2C3@C q6249[ 2 52J H96? E96 2:C H2D 4@=5 3FE E96 H2E6C H2D 7C66K:?8]k^Am
kAm“$@ x :>>6CD65 >JD6=7 2?5 H6?E :?E@ 42C5:24 2CC6DE[” rC@4<6C D2:5] w6 D2:5 9:D 92?5D H@C<65 3FE 9:D =68D 72:=65 2?5 96 4@F=5?’E DE2?5 FA 2?5 96 5C:7E65 @77]k^Am
kAm{:24@D D2:5 EH@ >6? 7@F?5 rC@4<6C 7246 5@H? 2?5 J6==65 7@C 96=A 2?5 {:24@D 96=A65 AF== 9:> @FE[ C@== 9:> @G6C 2?5 E96J DE2CE65 r!#] $96 D2:5 {@9?6D 42>6 7C@> E96 46?E6C “4@?46DD:@?” 2?5 3C@F89E E96 pts] {:24@D D2:5 2?@E96C ?FCD6[ ~’qC:6?[ 2=D@ 42>6 2=@?8]k^Am
kAm“p?5 27E6C H6 C6A62E65=J C@==65 9:> E@ 86E E96 H2E6C @FE @7 9:D =F?8D 2?5 H6 82G6 2 D9@4< 96 DE2CE65 3C62E9:?8[” D2:5 {:24@D[ H9@ 92D 25G@42E65 E@ 92G6 2? pts 2?5 2 7=2E 3@2C5 @? 6G6CJ =:768F2C5 DE2?5 2E E96 DAC2H=:?8 36249]k^Am
kAmk6>mtE92? u@C>2? >2J 36 4@?E24E65 2E hfgefdaf`c[ @C 2E k2 9C67lQ>2:=E@i67@C>2?o?@CE9@73@DE@?]4@>Qm67@C>2?o?@CE9@73@DE@?]4@>k^2m]k^6>mk^Am
[ad_2]
By Ethan Forman | Staff Writer
Source link
[ad_1]
The series premiere of The Penguin ends with its titular villain stripped naked and strapped to a chair as he’s tortured by Sofia Falcone. By the conclusion of the second episode, Sofia makes him an offer to join forces and seize control of the Falcone crime family—the most powerful mob in Gotham City. Life in Gotham is anything but predictable; one minute someone’s pointing a gun down your throat, and the next they’re asking you to help betray their family and make a play to take over the city’s criminal underworld.
This dramatic turn of events perfectly encapsulates the complicated relationship of Oswald “Oz” Cobb (Colin Farrell) and Sofia Falcone (Cristin Milioti) as they try to set aside their differences to take down Sofia’s uncle Luca (Scott Cohen) and fill the power vacuum created by the death of the infamous Carmine Falcone. Two episodes in, HBO’s The Batman spinoff series is quickly picking up momentum as Oz and Sofia’s tenuous partnership takes root and their respective quests to claim power in Gotham begin in earnest.
Although The Penguin is first and foremost a series about the villainous Oz Cobb, as Farrell reprises his scene-stealing character from Matt Reeves’s The Batman, Milioti’s Sofia Falcone is as much of a driving force in the spinoff as its central protagonist. Sofia has emerged as an unlikely contender to replace her father as Gotham’s crime lord, and the ways in which her character compares and contrasts with Oz have made their dynamic a compelling entry point into The Penguin’s developing story.
The pilot episode welcomes the show’s audience by thrusting them right back into the world of The Batman: A montage of news broadcasts serves as a recap of the 2022 film, reporting the rise in crime in Gotham after the Riddler’s terrorist attacks devastated the city and unearthed its deep-seated corruption. And, crucially, the broadcasts also cover the murder of Carmine Falcone and the ongoing power struggle to replace him. After all the exposition ends, The Penguin repositions Oz as the primary protagonist of this world in place of Robert Pattinson’s Batman. He kills Alberto Falcone (Michael Zegen), Sofia’s brother and the new head of the Falcone family, in an impulsive act that sets the events of the series in motion. At first, it seems as if Oz will be able to get away with his crime unscathed, but Sofia—fresh out of Arkham Asylum—arrives to upend his hastily conceived schemes.
In this week’s installment, “Inside Man,” The Penguin begins to uncover Sofia’s past and delve into the life of the notorious woman better known as “the Hangman.” The episode opens with a flashback of Alberto visiting her at Arkham Asylum, which bleeds into a present-day therapy session as her memories mix with her grief over the loss of her brother. The series proceeds to offer glimpses into Sofia’s life, shedding light on how she is perceived by the world. A radio show discusses how Sofia was technically exonerated for the murders of seven women but labels her a “psycho” and a “serial killer.” Outside of Alberto’s funeral, crowds gather with signs condemning the Falcone family and Sofia’s release from Arkham. At Alberto’s memorial service, conversations hush and turn to whispers when Sofia enters a room, highlighting the unease surrounding her. Even Sofia’s family members either fear her or refuse to take her seriously. (By the end of the episode, Luca and his lieutenants give Sofia the Godfather closing door treatment, shutting her out of the family business as Luca tries to send her away to Italy.)
Sofia and Oz are alike in many ways. Both are underestimated and overlooked by higher-ranking members of the crime family who fail to recognize their outsize ambitions and the threat they pose. Their immediate families are everything to them, with Sofia hell-bent on avenging her brother’s death and Oz caring for his mother, Francis (Deirdre O’Connell), who has early-onset dementia. They both face judgment and condescension from those around them, whether it’s due to Sofia’s past or Oz’s appearance, and neither takes such disrespect lightly.
For all their similarities, Sofia and Oz also carry themselves differently. Sofia is discreet and tries to keep a low profile, while Oz drives around in an opulent, purple-and-gold Maserati. Oz is a sweet talker, often wriggling his way out of dire situations, while Sofia is blunt and speaks plainly to cut through all the nonsense. Sofia grew up rich, with a powerful father; Oz grew up poor and has had to earn everything himself. They serve as perfect foils for each other as they reach for the same goal of controlling the city’s criminal empire. And, at least for now, they recognize each other’s potential to further their own agendas—even if they don’t trust each other.
As Sofia and Oz’s unlikely alliance begins, the audience knows there is little chance their partnership will work; one will surely betray the other at some point, particularly if Sofia ever discovers that Oz was the one who killed Alberto. Watching how their dynamic develops over the next six chapters of the eight-episode miniseries will be fascinating, especially as Milioti and Farrell get more space to play off each other. Milioti is as terrifying as she is mesmerizing as the ice-cold Sofia, and Farrell—fully transformed by impressive makeup and prosthetics—continues to put his own spin on an iconic villain between his menacing yet comical performance and an endlessly entertaining accent choice. (There is still nothing better in The Batman than the Penguin giving Batman and Gordon a lesson in Spanish.)
For a spinoff of The Batman that’s set within weeks of the movie’s events, The Penguin has mentioned the Caped Crusader’s name only once so far. (It has, however, referenced the Riddler several times already.) Creator Lauren LeFranc has managed to seamlessly weave this series into the world that Reeves is creating in his Batman films, keeping with their dark and grounded tone while also adding more levity to build on what worked so well with Oz’s character in the movie. By setting Batman aside, The Penguin expands this version of Gotham, showing how crime is proliferating in the city in the aftermath of the Riddler’s attacks through a smaller-stakes story centered on Gotham’s warring mafia families and the two oddballs trying to claw their way to the top. With Farrell and Milioti delivering captivating performances that showcase the many dimensions of their respective villains, The Penguin has already been a pleasant surprise that’s generating even more excitement for where Reeves’s ongoing Batverse and the new era of DC Studios could go from here.
[ad_2]
Daniel Chin
Source link
[ad_1]
How many cups of coffee do you find yourself drinking a day? One? Two? Maybe more? Well, a meta-analysis of cohort studies published in Nutrition, Metabolism & Cardiovascular Diseases found that there’s a specific number of cups that might have some favorable impacts on the risk of death and cardiovascular disease—especially in people with type 2 diabetes.
[ad_2]
[ad_1]
Heart surprised fans last month when they postponed their 2024 tour dates because Ann Wilson needed to undergo chemotherapy. The plan is for the band to return to the road in 2025.
Guitarist Nancy Wilson was asked by Ultimate Classic Rock whether those plans are still on track, and fortunately, they are.
Nancy said, “We’re coming back out in February. We’re rescheduling [the shows and] they’re about to be announced.”
Initially, when Heart’s tour dates were postponed, the reason cited was “due to medical reasons.” Following the band’s statement, Wilson took to social media to offer up some details regarding her health.
She wrote, “I recently underwent an operation to remove something that, as it turns out, was cancerous. The operations was successful, and I’m feeling great, but my doctors are now advising me to undergo a course of preventative chemotherapy, and I’ve decided to do it. And so, my doctors are instructing me to take the rest of the year away from the stage in order to fully recover.”
Wilson continued, “To the ticket buyers, I really do wish we could do these gigs. Please know that I absolutely plan to be back on stage in 2025. My team is getting those details sorted, and we’ll let you know the plan as soon as we can. Thank you all for the support. This is merely a pause. I’ve much more to sing.”
She concluded, “Respectfully, this is the last public statement I’d like to make on the matter.”
Jul 30 – Cleveland, OH @ Progressive Field (with Def Leppard & Journey)
Aug 1 – Ottawa, ON @ Canadian Tire Centre
Aug 2 – Toronto, ON @ Rogers Centre (with Def Leppard & Journey)
Aug 5 – Boston, MA @ Fenway Park (with Def Leppard & Journey)
Aug 7 – Quebec City, QC @ Videotron Centre
Aug 8 – Montreal, QC @ Bell Centre
Aug 10 – Albany, NY @ MVP Arena
Aug 11 – Buffalo, NY @ KeyBank Center
Aug 13 – Cincinnati, OH @ Heritage Bank Center
Aug 15 – Milwaukee, WI @ Fiserv Forum
Aug 16 – Hinckley, MN @ Grand Casino Hinckley Amphitheater
Aug 18 – Lincoln, NE @ Pinnacle Bank Arena
Aug 21 – Grand Rapids, MI @ Van Andel Arena
Aug 23 – Charleston, WV @ Charleston Coliseum
Aug 24 – Knoxville, TN @ Thompson Boling Arena at Food City Center
Aug 27 – Norfolk, VA @ Scope Arena
Aug 28 – Allentown, PA @ The Great Allentown Fair
Sept 17 – Portland, OR @ Moda Center
Sept 20 – West Valley City, UT @ Maverik Center
Sept 22 – Morrison, CO @ Red Rocks Amphitheatre (special guest TBD)
Sept 26 – San Francisco, CA – Chase Center
Sept 28 – Los Angeles, CA – Crypto.com Arena
Sept 29 – Phoenix, AZ – Footprint Center
Oct 2 – Lubbock, TX – United Supermarkets Arena
Oct 4 – Kansas City, MO – T-Mobile Center
Oct 5 – St. Louis, MO – Enterprise Center
Oct 8 – Houston, TX – Toyota Center
Oct 10 – Austin, TX – Moody Center
Oct 12 – North Little Rock, AR – Simmons Bank Arena
Oct 14 – Nashville, TN – Bridgestone Arena
Oct 16 – Greensboro, NC – Greensboro Coliseum
Oct 17 – North Charleston, SC – North Charleston Coliseum
Oct 19 – Charlottesville, VA – John Paul Jones Arena
Oct 21 – New York, NY – Madison Square Garden
Nov 13 – Birmingham, AL – Legacy Arena at BJCC
Nov 14 – Memphis, TN – FedExForum
Nov 16 – Wichita, KS – Intrust Bank Arena
Nov 19 – Des Moines, IA – Wells Fargo Arena
Nov 21 – Moline, IL – Vibrant Arena at The MARK
Nov 22 – Green Bay, WI – Resch Center
Nov 24 – Winnipeg, MB – Canada Life Centre
Nov 27 – Saskatoon, SK – Sasktel Centre
Nov 29 – Edmonton, AB – Rogers Place
Nov 30 – Calgary, AB – Scotiabank Saddledome
Dec 3 – Vancouver, BC – Pacific Coliseum
Dec 5 – Spokane, WA – Spokane Arena
Dec 7 – Boise, ID – Extra Mile Arena
Dec 9 – Sacramento, CA – Golden1 Center
Dec 12 – Bakersfield, CA – Mechanics Bank Arena (special guest TBA)
Dec 13 – San Diego, CA – Pechanga Arena
Dec 15 – Las Vegas, NV – Fontainebleau Las Vegas (An Evening With)
Erica Banas is a news blogger who’s been covering the rock/classic rock world since 2014. The coolest event she’s ever covered in person was the 2021 Rock & Roll Hall of Fame induction ceremony. (Sir Paul McCartney inducting Foo Fighters? C’mon now!) She’s also well-versed in etiquette and extraordinarily nice. #TransRightsAreHumanRights
[ad_2]
Erica Banas // Rock Music Reporter
Source link
[ad_1]
Blood pressure is one of those metabolic health markers you probably don’t think too much about unless you have a specific concern. Part of the reason people often ignore this factor until it’s pressing is that you have to measure your levels to know whether or not it should be a focus point, be it at the doctor or at home.
[ad_2]
[ad_1]
And based on the findings, it would appear vitamin D is just as essential as ever. Namely, the number of major cardiovascular events was 9% lower in the participants supplementing vitamin D compared to the placebo group, with the rate of heart attacks specifically being 19% lower, and an 11% lower chance of coronary revascularization, compared to the placebo.
[ad_2]
[ad_1]
Hannah Frye is the Assistant Beauty Editor at mindbodygreen. She has a B.S. in journalism and a minor in women’s, gender, and queer studies from California Polytechnic State University, San Luis Obispo. Hannah has written across lifestyle sections including health, wellness, sustainability, personal development, and more.
[ad_2]
[ad_1]
LOS ANGELES (AP) — Ann Wilson, lead singer of rock band Heart, says she has cancer.
The band is postponing the remaining shows on its Royal Flush Tour.
Wilson said in a statement Tuesday that she underwent a surgery to remove a cancerous growth and is recovering steadily, but that her doctors urged her to undergo preventive chemotherapy and take time off from performing “in order to fully recover.”
That meant the rest of the shows on the North American tour will be postponed to dates in 2025.
The band says all tickets purchased for the now-postponed shows will be honored and rescheduled dates will be announced in the coming weeks.
More about:
[ad_2]
Grant McHill
Source link
